![Silvano Cominelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Silvano Cominelli
Directeur Général chez
GianCom AG
Profil
Silvano Cominelli is currently Chief Executive Officer & Chief Investment Officer at GianCom AG since 2017.
Formerly, Dr. Cominelli was Director at Broncus Technologies, Inc. from 2007 to 2013, Director at Pelikan Technologies, Inc., Director-Neurology Business Unit at Serono SA from 1998 to 2000, and Investment Advisor at HBM Partners AG (Investment Management).
Dr. Cominelli earned a doctorate from the University of Zurich in 1999.
Postes actifs de Silvano Cominelli
| Sociétés | Poste | Début |
|---|---|---|
GianCom AG
 GianCom AG Investment ManagersFinance GianCom specializes in global equity investments, predominantly in growth sectors and compounders in the industries health care, technology, consumer and industrials with a focus on developed countries. The firm incorporates a fundamental, bottom-up stock picking process. Investment decisions are based on in-depth fundamental research into a company’s financial and business strengths/weaknesses, its growth prospect and unique industry positioning as well as the quality of management and capital returns. | Directeur Général | 20/09/2017 |
Anciens postes connus de Silvano Cominelli
| Sociétés | Poste | Fin |
|---|---|---|
Broncus Technologies, Inc.
 Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Develops solutions for diagnosing and treating lung diseases | Directeur/Membre du Conseil | 01/02/2013 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Corporate Officer/Principal | 01/12/2000 |
HBM Partners AG (Investment Management)
 HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs. | Analyst-Equity | - |
Pelikan Technologies, Inc.
 Pelikan Technologies, Inc. Medical SpecialtiesHealth Technology Develops hand held diagnostic and monitoring devices | Directeur/Membre du Conseil | - |
Formation de Silvano Cominelli
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Broncus Technologies, Inc.
Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Develops solutions for diagnosing and treating lung diseases | Health Technology |
Pelikan Technologies, Inc.
Pelikan Technologies, Inc. Medical SpecialtiesHealth Technology Develops hand held diagnostic and monitoring devices | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Health Technology |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HBM Partners AG (Investment Management)
HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs. | Finance |
GianCom AG
GianCom AG Investment ManagersFinance GianCom specializes in global equity investments, predominantly in growth sectors and compounders in the industries health care, technology, consumer and industrials with a focus on developed countries. The firm incorporates a fundamental, bottom-up stock picking process. Investment decisions are based on in-depth fundamental research into a company’s financial and business strengths/weaknesses, its growth prospect and unique industry positioning as well as the quality of management and capital returns. | Finance |
Choisissez Zonebourse 
